Loading stock data…
BSX
$56.42-0.42 (-0.75%)
Market OpenUpdated 11:42 AM EDT
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Boston Scientific Corporation in the Healthcare sector is trading at $56.85. The stock is currently near its 52-week low of $56.05, remaining 36.7% below its 200-day moving average. Technical signals show neutral RSI of 36 and bearish MACD signal, explaining why BSX maintains its current current market pressure. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 36) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$56.42
Potential Downside
27.5%
Whystock Fair Value$40.92
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus32 analysts
Mean target$85.19+51.0%
Range$60.00 – $110.00
Fundamentals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and tre...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$98.28B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
27.67
Beta
Defensive asset. Lower volatility than the S&P 500.
0.78
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.34%
Volume
Today's trading volume
3.73M
Recent News
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus
Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX), alleging misleading statements about the sustainability of U.S. electrophysiology growth. The cases focus on disclosures related to a key business segment and whether investors were given an accurate view of growth prospects. Several court ordered and attorney set deadlines are approaching for shareholders who may wish to participate in these actions. Boston Scientific is a large medical device...
Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock
We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Boston Scientific Corporation (NYSE:BSX) ranks 9th on this list. Boston Scientific Corporation (NYSE:BSX) has consistently featured in the 13F portfolio of Farallon Capital since the third quarter of 2020. Back then, this position comprised just under 8.3 million shares. The fund steadily […]
Boston Scientific AGM: $20B 2025 Sales, Governance Votes Pass, Special Meeting Proposals Fail
Boston Scientific (NYSE:BSX) used its 2026 Annual Meeting of Stockholders to highlight 2025 operating performance and review a slate of governance and compensation proposals, including competing measures related to shareholders’ ability to call special meetings. Management highlights 2025 results a
Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It?
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Is Boston Scientific Corporation (BSX) One of the Best Medical Device Stocks to Invest in Right Now?
Boston Scientific Corporation (NYSE:BSX) is one of the best medical device stocks to invest in right now. Argus cut the price target on Boston Scientific Corporation (NYSE:BSX) to $95 from $115 on April 27, reaffirming a Buy rating on the shares. The rating update came after the company’s fiscal Q1 earnings and guidance cut, with […]